Key result
Physicians' decisions to prescribe NOACs for atrial fibrillation are primarily influenced by their clinical experience, assessment of bleeding versus stroke risks, medication convenience, and patient out-of-pocket costs.
Population
7 physicians involved in atrial fibrillation management across community private practice, community…
Design
Other
Authors
Loading...
May guide education on bleeding-stroke tradeoffs and costs; leaves open whether targeting these factors improves NOAC uptake.
Under-treatment of atrial fibrillation persists due to physician unfamiliarity with NOACs, inaccurate bleeding risk assessment, and concerns over out-of-pocket costs, suggesting a need for targeted educational interventions.
Kirley et al. (2016) studied Atrial Fibrillation (n=7). NOACs vs. Warfarin was evaluated on Physicians' decision-making processes regarding anticoagulation management in AF (Qualitative themes). Physicians' decisions to prescribe NOACs for atrial fibrillation are primarily influenced by their clinical experience, assessment of bleeding versus stroke risks, medication convenience, and patient out-of-pocket costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: